These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 687166)

  • 1. Reduced protein loss during hemofiltration using Cuprophan membranes.
    Rubin JE; Adler AJ; Friedman EA; Berlyne GM
    Artif Organs; 1978 May; 2(2):131-3. PubMed ID: 687166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodiafiltration: a new alternative to hemofiltration and conventional hemodialysis.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Artif Organs; 1978 May; 2(2):150-3. PubMed ID: 687172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate clearance of small molecular weight solutes during hemofiltration using Cuprophan membranes.
    Rubin JE; Adler AJ; Friedman EA; Berlyne GM
    Artif Organs; 1978 May; 2(2):125-7. PubMed ID: 687164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to high ultrafiltration rates during closed batch hemodialysis.
    Man NK; Pils P; Di Giulio D; Zingraff J; Drueke T; Jungers P; Funck-Brentano JL
    Artif Organs; 1978 May; 2(2):154-6. PubMed ID: 687173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective on hemofiltration. An editorial introduction.
    Friedman EA
    Artif Organs; 1978 May; 2(2):119. PubMed ID: 687162
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of hemofiltration.
    Henderson LW
    Artif Organs; 1978 May; 2(2):120-4. PubMed ID: 687163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid fluid extraction with the Gambro Ultradiffuser.
    Lynggaard F; Nielsen B
    Artif Organs; 1978 May; 2(2):134-6. PubMed ID: 687167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The place of intermittent hemodialysis in the treatment of acute renal failure in the ICU patient.
    Lameire N; Van Biesen W; Vanholder R; Colardijn F
    Kidney Int Suppl; 1998 May; 66():S110-9. PubMed ID: 9573586
    [No Abstract]   [Full Text] [Related]  

  • 10. Extracorporeal treatment of acute renal failure: methods, indications, quantified and personalized therapeutic approach.
    Canaud B; Mion C
    Adv Nephrol Necker Hosp; 1995; 24():271-313. PubMed ID: 7572413
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
    Hörl WH; Riegel W; Schollmeyer P
    Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dialysis membranes on the convective transport of middle molecules.
    De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M
    Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes.
    Hörl WH; Steinhauer HB; Schollmeyer P
    Kidney Int; 1985 Nov; 28(5):791-6. PubMed ID: 3878906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical experience with MARS and Prometheus procedures].
    Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
    Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukopenia, hypoxia, and complement function with different hemodialysis membranes.
    Jacob AI; Gavellas G; Zarco R; Perez G; Bourgoignie JJ
    Kidney Int; 1980 Oct; 18(4):505-9. PubMed ID: 7230613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of small proteins--the stepchild of dialysis therapy. Protein permeability of different hemofiltration membranes analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
    Birk HW; Wizeman V
    Adv Exp Med Biol; 1987; 223():277-80. PubMed ID: 3447446
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemofiltration in uremia: clinical approach].
    Vantelon J; Lauriat F; Perrone B; Jeannot F
    J Urol Nephrol (Paris); 1977 Sep; 83(9):712-7. PubMed ID: 926235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.